Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2014, vol. 23, nr 3, May-June, p. 399–402

Publication type: original article

Language: English

Treatment of Camptodactyly Using Injection of Botulinum Neurotoxin

Maciej Urban1,2,A,B,C,D,E,F, Roman Rutowski2,A,B,C,D,E,F, Józef Urban2,A,B,C,E, Piotr Mazurek2,B,C, Sebastian Kuliński2,B,C, Jerzy Gosk1,2,A,B,C,D,E,F

1 Department of Traumatology, clinic of Traumatology and Hand Surgery, Wroclaw Medical University, Poland

2 Clinic of Traumatology and Hand Surgery, Wroclaw University Hospital, Poland

Abstract

Background. . camptodactyly is usually painless, not caused by trauma, often appearing bilaterally, gradually progressive flexion contracture of the proximal interphalangeal joint mainly on the 5th fingers.
Objectives. The aim of the study was to analyze the efficacy injecting botulinum neurotoxin in short muscles of the hand responsible for the contraction of the proximal interphalangeal joint.
Material and Methods. The clinical material consisted of 12 patients (8 women, 4 men) treated with injections of botulinum neurotoxin in 2009–2012. Patients were monitored respectively for 2 weeks, 3 and 6 months and then every six months after the procedure. The observation period after injection of toxin ranged from 18 to 36 months. Our proposed method of treatment is inducing a temporary paralysis of muscles (lumbrical, interosseous) by means of botulinum neurotoxin (botox).
Results. In the majority (10) of patients an improvement and stabilization was achieved just after one injection and there were no disease progression in subsequent controlled studies. These patients continued treatment with usage of redressing extensive splints. In case of the other two patients it was required to repeat the injections.
Conclusion. The preliminary results obtained are promising. This method of treatment requires further studies and long-term follow-ups every six months until release of symptoms of the disease will be achieved. The operative treatment is reserved for severe deformities.

Key words

camptodactyly, botulinum neurotoxin, botox, finger contracture.

References (21)

  1. Smith RJ, Kaplan EB: camptodactyly and similar atraumatic flexion deformities of the proximal interphalangeal joints of the fingers: a study of thirty-one cases. J bone Joint Surg 1968, 50a, 1187–1203.
  2. Landouzy L: camptodactylie. Stigmante precoce du neuroarthritisme. Presse Med 1906, 14, 251–253.
  3. Kozin SH, Kary SP: camptodactyly. In: Green’s Operative Hand Surgery. Eds.: Wolfe SW, Hotchkiss RN, Pederson Wc, Kozin SH, churchill livingstone Elsevier, Philadelphia 2011, 6th ed., 1443–1451.
  4. Jobe MT, Wright MT: congenital anomalies of hand. In: campbell’s operative orthopaedics. Ed.: crenshaw aH. Mosby Year book, St. louis 1992, 3415.
  5. Benson LS, Waters PM, Kamil NI, Simmons BP, Upton J: camptodactyly: classification and results of nonoperative treatment. J Pediatr Orthop 1994, 14, 814–819.
  6. Akawi NA, Ali BR, Al-Gazali L: a novel mutation in PRG4 gene underlying camptodactyly-arthropathy-coxa vara-pericarditis syndrome with the possible expansion of the phenotype to include congenital cataract. birth Defects Res a clin Mol Teratol 2012, 94, 553–556. doi: 10.1002/bdra.23031. Epub 2012 Jun 8.
  7. Malik S, Afzal M, Gul S, Wahab A, Ahmad M: autosomal dominant syndrome of camptodactyly, clinodactyly, syndactyly, and bifid toes. am J Med Genet a 2010, 152a, 2313–2317. doi: 10.1002/ajmg.a.33552.
  8. Choi BR, Lim YH, Joo KB, Paik SS, Kim NS, Lee JK, Yoo DH: camptodactyly, arthropathy, coxa vara, pericarditis (cacP) syndrome: a case report. J Korean Med Sci 2004 Dec, 19, 907–910.
  9. Hamilton KL, Netscher DT: Multidigit camptodactyly of the hands and feet: a case study. Hand 2013, 8, 324–329. doi: 10.1007/s11552-013-9497-6.
  10. Wieczorek D1, Bartsch O, Lechno S, Kohlhase J, Peters DJ, Dauwerse H, Gillessen-Kaesbach G, Hennekam RC, Passarge E: Two adults with Rubinstein-Taybi syndrome with mild mental retardation, glaucoma, normal growth and skull circumference, and camptodactyly of third fingers. am J Med Genet a 2009, 149a, 2849–2854. doi: 10.1002/ajmg.a.33129.
  11. Ozsahin M, Uslu M, Kutlucan A, Baki AE, Ataoglu S: bilateral fifth-finger camptodactyly. am J Phys Med & Rehab 2012, 91, 638. doi: 10.1097/PHM.0b013e318238a14b.
  12. Foucher G, Loréa P, Khouri RK, Medina J, Pivato G: camptodactyly as a spectrum of congenital deficiencies: a treatment algorithm based on clinical examination. Plast Reconstr Surg 2006, 117, 1897–1905.
  13. McFarlane RM, Classen DA, Porte AM, Botz JS: The anatomy and treatment of camptodactyly of the small finger. J Hand Surg 1992, 17a, 35–44.
  14. Hori M, Nakamura R, Inoue MD: Nonoperative treatment of camptodactyly. J Hand Surg 1987, 12a, 1061–1065.
  15. Rhee SH, Oh WS, Lee HJ, Roh YH, Lee JO, Baek GH: Effect of passive stretching on simple camptodactyly in children younger than three years of age. J Hand Surg am 2010, 35, 1768–1773.
  16. Miura T, Nakamura R, Tamura Y: long-standing extended dynamic splintage and release of an abnormal restraining structure in camptodactyly. J Hand Surg br 1992, 17, 665–672.
  17. Engeber WD, Flatt AE: camptodactyly: an analysis of sixty-six patients and twenty-four operations. J Hand Surg 1977, 2, 216–224.
  18. Siegert JJ, Cooney WP, Dobyns JH: Management of simple camptodactyly. J Hand Surg 1990, 15b, 181–189.
  19. Koman LA, Toby EB, Poechling GG: congenital flexion deformities of the proximal interphalangeal joint in children: a subgroup of camptodactyly. J Hand Surg 1990, 15a, 582–586.
  20. Akoz T, Erdogan B, Gorgu M, Kapucu MR, Girgin O: correction of camptodactyly with an external fixator. Eur J Plast Surg 1998, 21, 308–310.
  21. Domżał TM: Neurotoksyna botulinowa w praktyce lekarskiej. czelej, lublin 2009, 77–87.
© Wroclaw Medical University